3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Multiple Myeloma
60
Lymphoma
56
Leukemia, Myeloid, Acute
51
Leukemia
50
Lymphoma, Non-Hodgkin
48
Precursor Cell Lymphoblastic Leukemia-Lymphoma
46
Hodgkin Disease
36
Myelodysplastic Syndromes
28
Lymphoma, Large B-Cell, Diffuse
27
Breast Neoplasms
24
Lymphoma, Mantle-Cell
23
Neuroblastoma
22
Leukemia, Lymphocytic, Chronic, B-Cell
22
Burkitt Lymphoma
17
Lymphoma, Follicular
16
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
16
Central Nervous System Neoplasms
13
Lymphoma, Large-Cell, Immunoblastic
12
Sarcoma
11
Neoplasms, Plasma Cell
11
Brain Neoplasms
11
Recurrence
10
Lymphoma, B-Cell, Marginal Zone
10
Neoplasms
9
Hematologic Neoplasms
9
Congenital Abnormalities
9
Myeloproliferative Disorders
8
Leukemia, Myelomonocytic, Chronic
8
Leukemia, Biphenotypic, Acute
8
Graft vs Host Disease
8
Interventions
Rituximab
4
Valganciclovir
2
Valacyclovir
2
Carboplatin
2
Acyclovir
2
valomaciclovir
1
threonic acid
1
otelixizumab
1
cc-486
1
Zidovudine
1
Vincristine
1
Vaccines
1
Tomography, X-Ray Computed
1
Prednisone
1
Polymerase Chain Reaction
1
Methotrexate
1
Matrix-M
1
Magnesium Sulfate
1
MVA vaccine
1
Leucovorin
1
Kidney Transplantation
1
Interferons
1
In Situ Hybridization
1
Immunohistochemistry
1
Granulocyte Colony-Stimulating Factor
1
Gene-Eden-VIR
1
Gastrectomy
1
Flow Cytometry
1
Filgrastim
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Epstein-Barr Virus Infections
×
Granulocyte Colony-Stimulating Factor
×
Clear all
NCT00953420
2017-08-18
CADEN
Baylor College of Medicine
Phase 2
Completed
20 enrolled